CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 55 filers reported holding CYTEK BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,868,982 | -35.3% | 519,743 | +0.1% | 0.00% | – |
| Q2 2023 | $4,435,403 | -53.4% | 519,368 | -49.9% | 0.00% | – |
| Q1 2023 | $9,523,780 | +74.1% | 1,036,320 | +93.5% | 0.00% | -100.0% |
| Q4 2022 | $5,469,099 | -37.6% | 535,661 | -10.0% | 0.00% | 0.0% |
| Q3 2022 | $8,760,000 | +56.7% | 595,073 | +14.3% | 0.00% | 0.0% |
| Q2 2022 | $5,589,000 | +0.0% | 520,845 | +0.5% | 0.00% | – |
| Q1 2022 | $5,587,000 | -87.2% | 518,229 | -80.6% | 0.00% | -100.0% |
| Q4 2021 | $43,519,000 | -23.8% | 2,666,600 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $57,092,000 | – | 2,666,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Miura Global Management | 2,117,500 | $45,336,000 | 7.03% |
| RA Capital Management | 9,607,028 | $205,686,000 | 2.85% |
| Octagon Capital Advisors LP | 500,000 | $10,705,000 | 2.64% |
| HHLR ADVISORS, LTD. | 8,757,030 | $187,488,000 | 2.45% |
| REILLY FINANCIAL ADVISORS, LLC | 79,979 | $10,643,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 328,080 | $7,024,000 | 0.58% |
| Orbimed Advisors | 1,923,139 | $41,174,000 | 0.45% |
| PURA VIDA INVESTMENTS, LLC | 444,368 | $9,514,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 441,518 | $9,453,000 | 0.11% |
| FIL Ltd | 2,666,600 | $57,092,000 | 0.06% |